V6633
VEGF Receptor-3 (Flt-4)/Fc Chimera from mouse
>95% (SDS-PAGE), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder
别名:
Vascular Endothelial Growth Factor Receptor‑3
并加购，请在购物车里查看协议价、货期和发货地。
选择规格
变更视图
关于此项目
UNSPSC Code:
12352202
MDL number:
Biological source:
mouse
Recombinant:
expressed in baculovirus infected Sf21 cells
Assay:
>95% (SDS-PAGE)
Form:
lyophilized powder
Mol wt:
110-120 kDa by SDS-PAGE (glycosylation), calculated mol wt ~84.5 kDa
Impurities:
endotoxin, tested
biological source
mouse
recombinant
expressed in baculovirus infected Sf21 cells
assay
>95% (SDS-PAGE)
form
lyophilized powder
mol wt
110-120 kDa by SDS-PAGE (glycosylation), calculated mol wt ~84.5 kDa
packaging
pkg of 1 mg
storage condition
avoid repeated freeze/thaw cycles (Do not store in a frost-free freezer.)
impurities
endotoxin, tested
UniProt accession no.
storage temp.
−20°C
Gene Information
mouse ... Flt4(14257)
Application
VEGF Receptor-3 (Flt-4)/Fc Chimera from mouse is a disulfide-linked homodimeric protein consist of VEGF Receptor-3 fused with6X histidine tagged Fc portion of human IgG1 by a polypeptide linker. It may be used as a specific marker for lymphatic vessels as well as plays a pivotal role in the development of the lymphatic vessel system. The product was used to study the novel technique for pharmacological manipulation of blood and lymphatic vascularization in cultured mouse embryos ex vivo.
Biochem/physiol Actions
VEGF Receptor-3 (Flt-4) belongs to class III subfamily of RTKs and is expressed mainly in endothelial cells. VEGF Receptor-3 can block VEGF-C/D and inhibits lymphangiogenesis and lymphatic metastasis in orthotopic urinary bladder cancer (OUBC).
Physical form
Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline
Analysis Note
The activity is measured by its ability to bind human VEGF-D.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable